Infant Bacterial Therapeutics AB OMXSTO:IBT_B:
SAID ON THURSDAY SECURES PARTNERSHIP WITH BIOCONNECTION FOR PRODUCTION OF DRUG PRODUCT
DRUG PRODUCT PROCESS PERFORMANCE QUALIFICATION PROGRAMME TO BE CONDUCTED AT BIOCONNECTION’S MANUFACTURING FACILITY IN OSS, THE NETHERLANDS
Source text for Workspace:
Further company coverage: [IBTb.ST]
